HopeStage
Back to all studies
Active Not RecruitingNCT05032105

Focused ultrasound and anxiety in people with treatment-resistant epilepsy

About this titleRead the official source — NCT05032105

This study assesses anxiety symptoms.

Device studyAges 18–65United States
The study in practice

Understand this study

What is this study about?

This study assesses anxiety symptoms.

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
ColumbusSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 4, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
2
Sponsor
Ohio State University
Sponsor type
University
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05032105
Official title
Show the full official title

.An Open-label Clinical Trial Evaluating the ExAblate Model 4000 Type-1 Focused Ultrasound Unilateral Thalamotomy for Patients With Treatment-refractory Focal Onset Epilepsy and Comorbid Anxiety.

Recruitment & locations

Not recruiting

Columbus

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study assesses anxiety symptoms.

Who is behind this study?

The study sponsor is Ohio State University, a university.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies